National Bank of Canada’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
National Bank of Canada's BIIB Position: Q2 2026 in Review
National Bank of Canada increased its Biogen (BIIB) stake by 36% in Q2 2026, buying an estimated $5.46M and bringing the position to 107,416 shares worth $23.2M. The position accounts for 0.02% of the portfolio, ranked #508.
National Bank of Canada first reported a position in BIIB in Q4 2021 and has held it in 19 quarters since. The position peaked at $53.9M in Q4 2023. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- National Bank of Canada held 107,416 shares of Biogen worth $23.2M as of Q2 2026.
- National Bank of Canada bought 28,536 Biogen shares in Q2 2026, an estimated $5.46M.
- Biogen made up 0.02% of National Bank of Canada's portfolio in Q2 2026, its #508 holding.
- National Bank of Canada first reported a position in Biogen in Q4 2021 and has held it in 19 quarters since.
- National Bank of Canada's Biogen position peaked at $53.9M in Q4 2023.
- 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.